Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2375 of 3330
Next
>>
>
59351 to 59375 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.00213	uM	10880.155	0.9189	0.8918	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.00213	uM	10880.155	0.9189	0.8918	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.0107	uM	10880.155	0.9889	0.9853	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.0107	uM	10880.155	0.9889	0.9853	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.0533	uM	10880.155	0.9944	0.9926	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.0533	uM	10880.155	0.9944	0.9926	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.267	uM	10880.155	1.0171	1.0225	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	0.267	uM	10880.155	1.0171	1.0225	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	1.33	uM	10880.155	1.0436	1.0570	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	1.33	uM	10880.155	1.0436	1.0570	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	6.67	uM	10880.155	0.9649	0.9535	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	6.67	uM	10880.155	0.9649	0.9535	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	33.3	uM	10880.155	1.0693	1.0901	1.5205
AU565	HER2amp	Luminal	PD184352	MEK	MAPK	33.3	uM	10880.155	1.0693	1.0901	1.5205
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.000171	uM	10581.146	0.9766	0.9597	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.000171	uM	10581.146	0.9766	0.9597	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.000853	uM	10581.146	0.9236	0.8681	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.000853	uM	10581.146	0.9236	0.8681	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.00427	uM	10581.146	0.9128	0.8493	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.00427	uM	10581.146	0.9128	0.8493	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.0213	uM	10581.146	0.9765	0.9595	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.0213	uM	10581.146	0.9765	0.9595	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.107	uM	10581.146	0.9696	0.9477	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.107	uM	10581.146	0.9696	0.9477	1.1650
BT-20	TNBC	Basal A	PD184352	MEK	MAPK	0.533	uM	10581.146	0.9332	0.8847	1.1650

|<
<<
Previous
Page 2375 of 3330
Next
>>
>
59351 to 59375 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)